Ruxolitinib Phosphate
| CAS No. | 1092939-17-7 |
|---|---|
| MDL No. | MFCD18452860 |
| MF | C17H21N6O4P |
| MW | 404.40 |
| InChI Key | JFMWPOCYMYGEDM-XFULWGLBSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| - | - | On Request | On Request | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Product Information
Ruxolitinib phosphate is a phosphate salt formed by the reaction of ruxolitinib with one equivalent of phosphoric acid. It is used to treat patients with intermediate or high-risk myelofibrosis, including primary myelofibrosis, post-polycythemia vera myelofibrosis, and post-essential thrombocythemia myelofibrosis. It functions as an antineoplastic agent and an inhibitor of EC 2.7.10.2 (non-specific protein-tyrosine kinase). The compound contains ruxolitinib.
| CAS No. | 1092939-17-7 |
|---|---|
| Product Name | Ruxolitinib Phosphate |
Biological Targets
JAK1·JAK2
Associated Conditions
malaria·acute lymphoblastic leukemia·acute myeloid leukemia·polycythemia vera·alopecia areata·
* The information provided here is compiled from public sources and is for reference only.
